Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
   Rule 13d-1(b)
   Rule 13d-1(c)
   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  The securities beneficially owned by the reporting persons consist of (1) 3,704,462 shares of Common Stock, and (2) warrants to acquire 10,000,002 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on 39,978,693 shares of Common Stock, outstanding as of March 20, 2026, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The securities beneficially owned by the reporting persons consist of (1) 3,704,462 shares of Common Stock, and (2) warrants to acquire 10,000,002 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on 39,978,693 shares of Common Stock, outstanding as of March 20, 2026, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The securities beneficially owned by the reporting persons consist of (1) 3,704,462 shares of Common Stock, and (2) warrants to acquire 10,000,002 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on 39,978,693 shares of Common Stock, outstanding as of March 20, 2026, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The securities beneficially owned by the reporting persons consist of (1) 3,704,462 shares of Common Stock, and (2) warrants to acquire 10,000,002 shares of Common Stock, which warrants are subject to a 9.99% beneficial ownership limitation. The percentage reported herein is calculated based on 39,978,693 shares of Common Stock, outstanding as of March 20, 2026, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2025.


SCHEDULE 13G



 
Stonepine Capital Management, LLC
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:03/27/2026
 
Stonepine Capital, L.P.
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member of the General Partner, Stonepine GP, LLC
Date:03/27/2026
 
Stonepine GP, LLC
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:03/27/2026
 
Jon M. Plexico
 
Signature:/s/ Jon M. Plexico
Name/Title:Reporting person
Date:03/27/2026
Exhibit Information

EXHIBIT 99 - AGREEMENT REGARDING JOINT FILING OF STATEMENT ON SCHEDULE 13D OR 13G


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

AGREEMENT RE JOINT FILING